Awardee OrganizationALBERT EINSTEIN COLLEGE OF MEDICINE
Description
Abstract Text
DESCRIPTION (provided by applicant):
We propose to determine the mechanisms that cause vasoconstriction when cell free
hemoglobins are introduced into the circulation as the O2 carrier of an O2-carrying plasma
expander (OCPE) by studying the vascular effects produced by polyethylene glycol (PEG)
surface decorated hemoglobins (HbS) developed in this program. We will study the presser
response to top loads of various formulations and quantify the reactions of the microcirculation
in the hamster skinfold model, which can be studied without anesthesia, in the awake condition
for periods of up to 2 weeks. The principal microvascular parameters to be evaluated in vivo
are functional capillary density and intravascular oxygen tension distribution. Tests will analyze
different hypothesis on the genesis of vasoactivity due to molecular hemoglobin in the
circulation, namely: 1) NO scavenging by hemoglobin; 2) lowered viscosity in hemodilution,
leading to lowered shear stress and production of endothelial relaxing factors; 3) Increased
facilitated diffusion and O2 autoregulation by oxyhemoglobin; and, 4) Extent of hemoglobin
surface shielding by PEG molecules. Efficacy of the OCPEs will be determined in conditions of
isovolemic hemodilution and hemorrhagic shock. An effective OCPE must also insure
sufficiently elevated blood viscosity, which is necessary for the maintenance of adequate
microvascular function, and condition that can be obtained with PEG-Hbs. In hemodilution
these molecules increase plasma viscosity, causing redistribution of hydraulic pressure in the
circulation, decreasing systemic viscosity dependent pressure losses and increasing peripheral
resistance. Additionally the O2 dissociation curve for these modified hemoglobins should be left
shifted, so O2 release occurs only in anoxic regions and not from arterioles and where tissue
oxygenation is adequate. Our goal is to obtain an understanding of vasoactivity in support of
OCPE development that prioritizes maintenance of microvascular function in terms of capillary
perfusion, which is as critical for tissue survival as adequate oxygenation, by using methods for
the analysis at the cellular microscopic level, where blood performs its vital functions.
No Sub Projects information available for 1P01HL071064-01 0005
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P01HL071064-01 0005
Patents
No Patents information available for 1P01HL071064-01 0005
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P01HL071064-01 0005
Clinical Studies
No Clinical Studies information available for 1P01HL071064-01 0005
News and More
Related News Releases
No news release information available for 1P01HL071064-01 0005
History
No Historical information available for 1P01HL071064-01 0005
Similar Projects
No Similar Projects information available for 1P01HL071064-01 0005